Business
Press Release Sep 23 2025
Marksans Pharma Limited has informed the Exchange regarding a press release dated September 23, 2025, titled "Marksans Pharma Ltd's subsidiary Relonchem Limited in UK received marketing authorisation for its products from UK MHRA.".
About this update from Marksans Pharma Limited
[{"type":"text","content":" Marksans Pharma Limited has informed the Exchange regarding a press release dated September 23, 2025, titled \"Marksans Pharma Ltd's subsidiary Relonchem Limited in UK received marketing authorisation for its products from UK MHRA.\". View Attachment","length":377,"tagName":"div"}]